Coppell Advisory Solutions’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Coppell Advisory Solutions's PCRX Position: Q3 2026 in Review
Coppell Advisory Solutions sold out of Pacira BioSciences (PCRX) in Q3 2026, closing a stake of 16 shares — an estimated $5.59M sold.
Coppell Advisory Solutions first reported a position in PCRX in Q2 2024 and held it in 2 quarters. The position peaked at $5.59M in Q2 2026. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- Coppell Advisory Solutions reported no remaining Pacira BioSciences position as of Q3 2026 after selling out during the quarter.
- Coppell Advisory Solutions sold 16 Pacira BioSciences shares in Q3 2026, an estimated $5.59M.
- Coppell Advisory Solutions first reported a position in Pacira BioSciences in Q2 2024 and held it in 2 quarters.
- Coppell Advisory Solutions's Pacira BioSciences position peaked at $5.59M in Q2 2026.
- 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on Coppell Advisory Solutions's 13F filing for Q3 2026, filed 16 Nov 2026.